/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | GNPXGenprex, Inc. |
|---|---|
| Last close | $2.31close 2026-11-03 |
| Change % | +3.59%close 2026-11-03 |
| Market cap | $2Mclose 2026-11-03 |
| P/E | loss, no P/E |
| Revenue | $0⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2024-12-31 Filing10-K · 0001437749-25-010311 · filed 2025-04-01 Open the filing on EDGAR →Open the XBRL payload →CiteGenprex, Inc. (GNPX), us-gaap:Revenues: 0 USD, fiscal year ended 2024-12-31. Form 10-K, accession 0001437749-25-010311, filed 2025-04-01. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001595248/us-gaap/Revenues.json |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | no prior year filed |
| Net income | $-16228953⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEF 14A · 0001437749-26-013906 · filed 2026-04-29 Open the filing on EDGAR →Open the XBRL payload →CiteGenprex, Inc. (GNPX), us-gaap:NetIncomeLoss: -16,228,953 USD, fiscal year ended 2025-12-31. Form DEF 14A, accession 0001437749-26-013906, filed 2026-04-29. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001595248/us-gaap/NetIncomeLoss.json |
| Net margin | periods differ |
| EPS (diluted) | $-0.42⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareBasicAndDiluted As ofFY ending 2021-12-31 Filing10-K · 0001437749-22-007680 · filed 2022-03-30 Open the filing on EDGAR →Open the XBRL payload →CiteGenprex, Inc. (GNPX), us-gaap:EarningsPerShareBasicAndDiluted: -0.42 USD per share, fiscal year ended 2021-12-31. Form 10-K, accession 0001437749-22-007680, filed 2022-03-30. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001595248/us-gaap/EarningsPerShareBasicAndDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 2FY to 2024-12-31 |
| Altman Z-ScoreUNVALIDATED | -69.16FY to 2024-12-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | — |